This study aimed to examine the role of QLQ-C15-PAL scores and the inflammatory biomarkers CRP, Alb, and NLR for survival prediction to help avoid discomfort and inappropriate therapies in terminally ill patients with cancer. This evidence concerns the gene CRP and cancer.